Pandemic News and Research

RSS
A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Further Reading

SEEK reports Phase I safety trail for investigational flu vaccine

SEEK reports Phase I safety trail for investigational flu vaccine

8 Dec 2010
Studies highlight need for new antiviral treatment options and strategies

Studies highlight need for new antiviral treatment options and strategies

7 Dec 2010
Experimental flu vaccine triggers immune response, protects against flu

Experimental flu vaccine triggers immune response, protects against flu

7 Dec 2010
Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

6 Dec 2010
Patients with H1N1 flu die due to over-reactive immune response: Research

Patients with H1N1 flu die due to over-reactive immune response: Research

6 Dec 2010
IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

4 Dec 2010
IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

4 Dec 2010
White House marks World AIDS Day

White House marks World AIDS Day

2 Dec 2010
Baxter licenses Vero cell-based influenza vaccine technology to Takeda

Baxter licenses Vero cell-based influenza vaccine technology to Takeda

From Baxter International Inc. 2 Dec 2010
More effective treatment for severe form of influenza

More effective treatment for severe form of influenza

2 Dec 2010
World AIDS Day to mark start of international effort to shed light on how public funds are used

World AIDS Day to mark start of international effort to shed light on how public funds are used

1 Dec 2010
New book investigates past influenza pandemics

New book investigates past influenza pandemics

1 Dec 2010
Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

1 Dec 2010
PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

1 Dec 2010
Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

1 Dec 2010
University of Adelaide researcher leads collaboration for universal flu vaccine

University of Adelaide researcher leads collaboration for universal flu vaccine

30 Nov 2010
Medicago, Genopole expand collaboration

Medicago, Genopole expand collaboration

26 Nov 2010
Media outlets continue to follow major HIV/AIDS developments this week

Media outlets continue to follow major HIV/AIDS developments this week

25 Nov 2010
GCM supports iPrEx Study to prevent HIV infection among MSM

GCM supports iPrEx Study to prevent HIV infection among MSM

24 Nov 2010
Important queries about PrEP, iPrEx trial for HIV infection

Important queries about PrEP, iPrEx trial for HIV infection

24 Nov 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback